Biomaterials | Tissue Engineering | Spain | Madrid

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

Key Trends in Biomaterials and Tissues Engineering

- Biomaterials 2023

Welcome Message

On behalf of our international organizing committee, it’s our pleasure to extend a warm welcome to all of you at this year's "6th International Conference on Biomaterials and Tissue Engineering". The Biomaterials Conferences 2023 will focus on "Key Trends in Biomaterials and Tissues Engineering" and we are glad to inform and educate you about this. As we come together for this important event at city of Madrid, Spain, well known for its historical buildings, food markets, and the dates October 16-18, 2023.

We have gathered here today to discuss the latest research, advancements, and best practices in the field of Biomaterials. Keynote addresses, panel discussions, interactive workshops, and poster presentations will be on the program elements of our Biomaterials Conference in 2023. These sessions will provide us with valuable insights and perspectives on Biomaterials, Tissue Engineering and allow us to learn from each other's experiences.

The topics that we will cover are varied and include emerging trends, innovative treatments using Biomaterials, and best practices in biomedical instruments. At this Biomaterials Conference 2023, we have the opportunity to strengthen our connections, engage in meaningful conversations, and work together to advance the field of Biomaterials. We believe that by sharing our knowledge and expertise, we can create better health outcomes.

We would like to express our gratitude to the organizers, sponsors, and presenters for making this event Biomaterials Conference 2023 possible. I hope that you find the Biomaterials Conference 2023 possible to be engaging and informative, and I look forward to the insights and discussions that will take place over the next few days.

Kind Regards,

Ms.Katherine Simon
Program Manager | Biomaterials 2023
E: [email protected]
W: +44 7389643840

About

The annual Biomaterials 2023 conference brings together biomedical engineers, biomedical specialists, and other allied professionals.

The newest and most recent subjects in biomaterials and tissues will be covered at the Biomaterials 2023 conference. With a focus on basic, clinical, and translational sciences as they advance toward a deeper knowledge of Biomaterials and Tissues, the scientific program has been improved to have more interaction, discussion, and learning opportunities.

Networking with peers in the biomaterials industry from around the world with a variety of specialties and backgrounds is another opportunity presented by the Biomaterials Conference 2023.

We anticipate your active participation and are forward to meeting you in Spain!

Format of the Conference

Both an in-person and online version of this biomaterials and tissues conference will be held. View this event online from your home or place of business. After the Biomaterials conference, recordings will be made available. You can watch the recordings later if you missed any lectures. Sessions on demand will be made available following the Biomaterials conference. You will have access to all lecture videos and handouts for a period of six months.

Biomedical Engineers
Tissue Engineers
Surgeons and Doctors
Biomedical researchers, and professionals
Academic Experts in Biomaterials & Biodevices
Investors & Entrepreneurs
Organizations in the Material & Devices Sectors
Industry Leaders, Government Leaders
Biomaterial Science Specialists
Nanotechnology Specialists
Nanomaterials Specialists
Research Institutions
Young Researchers & Student Researchers

What's New?

Dedicated tracks for Biomaterials, Tissues, and Ninthis Biomaterials Conference
Hands-on training workshops with international Otolaryngology experts
Over 50 scientific poster presentation
More international guest speakers from the USA, Canada, Australia, Europe, Asia, and the GCC region

Sessions & Tracks

Scientific Sessions

Tissue Engineering
Drug Delivery Systems
Orthopedic Implants
Cardiovascular Devices
Wound Healing and Regeneration
Bioactive Materials
Biosensors
Nanobiomaterials
Biodegradable Materials
Biocompatibility and Immunomodulation
Stem Cell Engineering
Neural Interfaces
Ophthalmological Applications
Bioinspired and Biomimetic Materials
Biomaterials for Gene Therapy

Session on Tissue Engineering

Tissue Engineering in biomaterials is a rapidly expanding sector within the global regenerative medicine market. According to Market Research Future, the tissue engineering market is predicted to reach approximately $53.2 billion by 2027, growing at a CAGR of 17.84% during 2020-2027. This growth in biomaterials is driven by technological advancements, increased prevalence of chronic diseases, and the rising geriatric population globally. Additionally, the increased investment in R&D and higher demand for organ transplantation are expected to propel the market forward. However, high costs and regulatory challenges may hinder market growth. Nevertheless, potential breakthroughs in biomaterials and stem cells present immense opportunities for this sector.

Sub Track

Cartilage Tissue Engineering
Bone Tissue Engineering
Skin Tissue Engineering

Related Conference

Related Societies

Australasian Society for Biomaterials and Tissue Engineering | European Society for Biomaterials | Society for Biomaterials & Artificial Organs (India) | The Korean society for biomaterials | United Kingdom Society for Biomaterials | The Scandinavian Society for Biomaterials | Canadian Biomaterials Society.

Related Association

Related Journals

Journal of Biomaterials and Tissue Engineering | Journal of Tissue Engineering - SAGE Journals | Journal of Biomaterials Applications - SAGE Journals | Journal of Tissue Engineering and Regenerative Medicine | International Journal of Nano and Biomaterials

Session on Drug Delivery Systems

The global Drug Delivery Systems market in biomaterials is projected to experience significant growth, fueled by increasing prevalence of chronic diseases, technological advancements, and the rise in biologics and biosimilars in biomaterials. According to a report by Grand View Research, the market size is expected to reach approximately $900.3 billion by 2028, growing at a CAGR of 5.4% from 2021. The development of targeted drug delivery systems and nanotechnology has particularly sparked interest. However, stringent regulatory frameworks and high development costs pose challenges. Despite these hurdles, ongoing R&D in personalized medicine and combination therapies present promising opportunities in this dynamic market.

Sub Track

Nanoparticle-Based Delivery Systems
Viral Vector-Based Gene Delivery
Biomaterials for Delivery Systems

Related Conference

Related Societies

Related Association

Related Journals

Journal of Biomaterials and Tissue Engineering | International Journal of Biomaterials | Journal of Tissue Engineering - SAGE Journals | Journal of Biomaterials Applications - SAGE Journals | Journal of Tissue Engineering and Regenerative Medicine | International Journal of Nano and Biomaterials

Session on Orthopedic Implants

The global orthopedic implants in biomaterials market is poised for robust growth, driven by an aging global population, increased prevalence of osteoporosis and osteoarthritis, and advancements in implant technologies. According to Markets, the market is predicted to reach around $64.0 billion by 2027, at a CAGR of approximately 4.6% from 2022 to 2027. The growing popularity of minimally invasive surgeries and the rise of 3D-printing in orthopedics are significant growth factors. However, the market faces hurdles like strict regulatory scrutiny and the high cost of procedures. Emerging markets, personalized orthopedic implants, and bioabsorbable implants in biomaterials are seen as potential growth opportunities.

Sub Track

Fracture Fixation Devices
Orthopedic Joint Revision Implants
Bone Grafts and Bone Substitutes

Related Conference

Related Societies

Related Association

Related Journals

Session on Cardiovascular Devices

The cardiovascular devices market, especially those utilizing biomaterials, is seeing notable growth, driven by the rising incidence of cardiovascular diseases (CVDs), an aging population, and technological advancements. According to a report by Fortune Business Insights, the market is projected to reach around $60.3 billion by 2027, registering a CAGR of 6.4% from 2020. The development of innovative biomaterials for devices like stents, heart valves, and pacemakers are key growth stimulators. Nevertheless, the high cost of devices and stringent regulatory policies may restrict growth. Future market expansion is anticipated through the advent of bioresorbable stents and novel biomaterials.

Sub Track

Cardiac Implantable Electronic Devices
Coronary Stents
Implantable Cardiovascular Monitors

Related Conference

Related Societies

Related Association

Related Journals

Session on Wound Healing and Regeneration

The global market for biomaterials in wound healing and regeneration is experiencing substantial growth. Factors driving this include a rise in chronic conditions like diabetes, an aging global population, and increasing demand for advanced wound care therapies. According to Meticulous Research, this market is expected to reach approximately $29.7 billion by 2027, growing at a CAGR of 6.5% from 2020. Despite potential hindrances like high costs and regulatory issues, the advent of innovative biomaterials for wound dressings and regenerative medicine opens new growth avenues. The focus on biocompatible, biodegradable, and antimicrobial materials underscores this dynamic market's potential.

Sub Track

Tissue Scaffolds
Cell-Based Therapies
Immunomodulatory Biomaterials

Related Conference

Related Societies

Related Association

Related Journals

Session on Bioactive Materials

The global BioactiveMaterials market is expanding significantly, driven by the growing prevalence of chronic diseases, rising geriatric population, and increased demand for medical implants. As per a report by Transparency Market Research, this market is projected to reach $55.85 billion by 2027, growing at a CAGR of 6.4% from 2019 to 2027. Bioactive materials' of biomaterials has the ability to interact with biological systems and promote healing is driving their use in diverse applications, particularly in dentistry and orthopedics. However, high costs and stringent regulatory processes may impede growth. Nevertheless, advancements in bioactive glass and ceramics offer substantial opportunities in this promising market.

Sub Track

Bioactive Coatings and Surface Modifications
Tissue Engineering and Organoids
Bioactive Materials for Neural Regeneration

Related Conference

Related Societies

Related Association

Related Journals

Session on Biosensors

The global biosensors market is exhibiting robust growth, fueled by the escalating prevalence of chronic and lifestyle-induced diseases, the need for point-of-care testing, and advances in nanotechnology. According to Markets, the biosensors market is expected to reach approximately $36.7 billion by 2026, growing at a CAGR of 7.5% from 2021 to 2026. Biosensors' adaptability for integration into different devices and a rise in demand for glucose monitoring systems are key growth drivers. While regulatory hurdles and pricing pressure may challenge the growth, emerging markets and non-invasive biosensors offer significant opportunities for the industry.

Sub Track

Nanomaterial-Based Biosensors
Implantable Biosensors
Biosensor Signal Transduction

Related Conference

Related Societies

Related Association

Related Journals

Session on Nanobiomaterials

The global nanobiomaterials market is witnessing substantial growth, driven by their increasing application in drug delivery, regenerative medicine, and diagnostics. According to a report by Allied Market Research, this market is projected to reach $11.9 billion by 2025, registering a CAGR of 12.3% from 2018 to 2025. The development of advanced nanobiomaterials, especially for targeted therapy, has spurred significant interest. Despite potential challenges such as high costs and stringent regulatory issues, innovative applications in areas like tissue engineering, orthopedics, and dentistry, along with increased investment in nanotechnology research, present substantial growth opportunities.

Sub Track

Nanosensors and Diagnostics
Nanostructured Surfaces for Implants
Nanoparticles for Drug Delivery

Related Conference

Related Societies

Related Association

Related Journals

Session on Biodegradable Materials

The global biodegradable materials market is experiencing rapid growth due to the escalating environmental concerns and stringent government regulations against conventional plastics. According to a report by MarketsandMarkets, the market is projected to reach around $6.7 billion by 2026, at a CAGR of 13.4% from 2021. Biodegradable materials' potential in reducing waste and their increasing applications in sectors like packaging and agriculture are propelling the market. Despite challenges like high costs and limited availability, advancements in research and development for new applications, particularly in the medical field for drug delivery and implants, present promising market opportunities.

Sub Track

Bioactive Coatings and Surface Modifications
Tissue Engineering and Organoids
Bioactive Materials for Neural Regeneration

Related Conference

Related Societies

Related Association

Related Journals

Session on Biocompatibility and Immunomodulation

The market for biocompatibility and immunomodulation, critical considerations in the development of biomedical devices and materials, is witnessing significant growth. This is driven by increasing prevalence of chronic diseases, aging populations, and advances in biomaterials science. While exact market size figures are challenging to delineate due to the intersectionality of fields, the overall biomaterials market, underpinned by biocompatibility and immunomodulation, is expected to reach $297 billion by 2022 according to a report by MarketsandMarkets. Despite potential regulatory and biocompatibility challenges, the escalating demand for innovative medical implants and therapies offer considerable opportunities.

Sub Track

Material-Specific Biocompatibility
Immunomodulatory Drug Delivery Systems
Biodegradable Materials and Biocompatibility

Related Conference

Related Societies

Related Association

Related Journals

Session on Stem Cell Engineering

The global market for Stem Cell Engineering in biomaterials is experiencing robust growth driven by advancements in regenerative medicine and the need for novel therapies for chronic diseases. According to a report by Fortune Business Insights, the stem cells market, a related sector, is projected to reach $50.4 billion by 2027, at a CAGR of 6.6% from 2020. Stem cell engineering's role in creating therapies for conditions like cancer, neurodegenerative disorders, and cardiac diseases is propelling this market. Although ethical considerations and regulatory hurdles pose challenges, the potential for breakthroughs in personalized medicine and tissue engineering presents significant opportunities.

Related Conference

Related Societies

Related Association

Related Journals

Sub Track

Differentiation and Tissue Engineering
Stem Cell Bioprocessing
Biomaterials and Stem Cells

Session on Neural Interfaces

The Neural Interfaces market is expanding rapidly, fueled by the rising prevalence of neurological disorders and technological advancements in neurology. According to a report by Markets and Markets, the overall neuroprosthetics market, a closely related sector, is expected to reach $10.48 billion by 2025, growing at a CAGR of 12.4% from 2020. The development of advanced neural interfaces for restoring sensory and motor functions is a key growth stimulator. Regulatory challenges and the high cost of devices may restrict growth, but the emergence of novel biomaterials for interfacing with the nervous system offers substantial market opportunities.

Related Conference

Related Societies

Related Association

Related Journals

Sub Track

Intracortical Interfaces
Optogenetics
Neural Interface Materials and Implantable Devices

Session on Ophthalmological Applications

The global market for ophthalmological applications of biomaterials is witnessing steady growth, driven by an aging population, a rising prevalence of eye diseases, and advancements in biomaterials science. According to a report by Transparency Market Research, the global ophthalmic devices market is projected to reach around $58 billion by 2025, at a CAGR of around 4% from 2017. Biomaterials are pivotal in developing intraocular lenses, contact lenses, and other ocular implants. Despite regulatory challenges and high costs, the innovation in ocular drug delivery systems and the advent of bio-inspired materials present substantial growth opportunities in this market.

Sub Track

Retinal Implants and Prosthetics
Ophthalmic Imaging and Diagnostics
Retinal Implants and Prosthetics

Related Conference

Related Societies

Related Association

Related Journals

Session on Bioinspired and Biomimetic Materials

The Bioinspired and Biomimetic Materials market is witnessing significant growth driven by increased R&D activities and a growing focus on sustainable development. While specific market data is limited due to the niche nature of this field, it plays a critical role in the broader biomaterials market, expected to reach $240.3 billion by 2026, as per a report by Fortune Business Insights. These biomaterials' ability to mimic natural biological systems opens up opportunities in various sectors, from medical to environmental applications. While technical and scale-up challenges exist, their potential in delivering innovative, sustainable solutions offers substantial market opportunities.

Sub Track

Biomedical Materials
Bioelectronics and Sensing
Bioactive and Biodegradable Scaffolds

Related Conference

Related Societies

Related Association

Related Journals

Session on Biomaterials for Gene Therapy

The market for biomaterials in gene therapy is experiencing robust growth, driven by advancements in genetic engineering and the rising prevalence of genetic disorders. According to a report by Allied Market Research, the global gene therapy market is projected to reach $6.21 billion by 2026, growing at a CAGR of 33.6% from 2019 to 2026. The development of innovative biomaterial based vectors for safer and more efficient delivery of therapeutic genes is a key market stimulator. While technical challenges and regulatory hurdles exist, the potential of gene therapies in treating currently incurable diseases presents immense market opportunities.

Sub Track

Targeted Gene Delivery
Gene Editing Biomaterials
Viral Vector Biomaterials

Related Conference

Related Societies

Related Association

Related Journals

Registration Details

The $899 in-person package incorporates:

Presentations made by our skilled team
Following each webinar, the instructor will conduct a Q and A session.
Modern assessment of Biomaterials and technologies at the moment
Resources for every session
Within one week after each live session, access to FREE proceedings and recordings is available for one whole year.

For details on the additional registrations for the conference, go to https://biomaterials.alliedacademies.com/

Bulk Booking Discount

Get a 10% discount on each participant's registration price when you sign up as a group participant with a minimum of 5 participants.

To take advantage of this offer, write an email to [email protected] with all five names.

You may find more information at https://biomaterials.alliedacademies.com

Market Analysis

The size of the global biomaterials market was estimated at USD 135.4 billion in 2021 and is projected to increase at a CAGR of 15.4% between 2022 and 2030. The demand for biomaterial-based implants is anticipated to increase due to the increased prevalence of musculoskeletal and chronic skeletal medical disorders, which will accelerate market expansion. Another reason boosting demand for orthopedic implants is the aging population, which is more susceptible to musculoskeletal issues like osteoarthritis and osteoporosis. A variety of biomaterials and biomedical tools are needed for coronavirus diagnosis and treatment. Early virus detection is essential in this pandemic to stop the further spread of the disease. Using currently available biomedical technologies that are based on either Polymerase Chain Reaction (PCR) or Non-PCR approaches, infection from COVID-19 can be detected.

Biomaterial technologies support the development of novel, efficient personal protection equipment, medicine delivery systems, vaccines, and innovative therapeutics for the SARS-COV-2 disease. Furthermore, cell-cultured models and engineered tissues had a significant impact on the research of infection, testing, and creation of vaccines and medications. As a result, the market has given rise to a range of designs for diagnostic and therapeutic tools for the management of COVID-19, such as rapid and accurate diagnostic platforms, state-of-the-art vaccines, potent antiviral drugs, and efficient laboratory access models. Thanks to technological advancements in fields of medicine like tissue engineering and bioengineering, biomaterials are becoming more practical and flexible.

Regional Analysis:

With a 38.2% revenue share in 2021, North America dominated the market as a result of the initiatives taken by several public and private organizations. They provide information and assistance about the use of biomaterials in biological applications, two of which are the National Science Foundation and the National Institute of Standards and Technology. As a result, the usage of biomaterials in this field has increased. Additional factors including favorable government policies and the presence of multiple prominent market players in this region have also had an impact on the regional market share.

The Asia Pacific market is predicted to see the highest CAGR over the course of the forecast period as a result of strategic initiatives made by regional participants to improve their position in both domestic and international markets. For instance, in November 2019, the thermoplastic polyurethane elastomer businesses of the U.S.-based AdvanSource Biomaterials and the Japan-based Mitsubishi Chemical agreed to be acquired by the other. The business believes that this acquisition will help it expand abroad and capture a sizeable share of the global market. India's biomaterials market is constantly growing. The Indian biomaterials market is dominated by orthopedic, dental, and cardiovascular biomaterials. Growing market shares for biomaterial, cardiovascular, and orthopedic products are caused by an increase in orthopedic, cardiovascular, and dental procedures.

Key Companies

Dentsply Sirona
Carpenter Technology Corporation
Berkeley Advanced Biomaterials
Medtronic plc
Evonik Industries AG
Invibio Ltd.
Zimmer Biomet Holdings, Inc.
Johnson & Johnson
CoorsTek Inc.
BASF SE
Covalon Technologies Ltd.
Stryker

Organizing committee members

Chandra P. Sharma

Former Senior Scientist & Head, Biomedical Technology Wing

Sree Chitra Thirunal Institute of Medical Sciences and Technology, Biomedical Technology Wing, India

Sergey Suchkov

Professor, Immunology & Medicine

MINO MGUPP, Russia

Shu Chien

Director, Institute of Engineering In Medicine, UC San Diego, Bioengineering

University of California, USA

Bharat Bhushan

Professor

The Ohio State University, USA

Ramesh K. Agarwal

Professor

Washington University Washington University michigan, USA

Renowned Speakers

Dunja Milicic

Hospital da Luz Arrabida, Portugal

Manya Thakur Roy

Pt JNM Medical College, India

Aroonsri priprem

Khon Kaen University Bangkok, Thailand

Ramesh K. Agarwal

Professor, Washington University

Washington University, USA

Bharat Bhushan

The Ohio State University, USA

To Collaborate Scientific Professionals around the World

Conference Date	October 16-18, 2023
Poster Oppurtunity	Available
e-Poster Oppurtunity	Available

Testimonials

Sergey Suchkov

MINO MGUPP

The Conference has been an awesome platform to connect and collaborate. Hope to attend next year too.

Shu Chien

University of California

I hope there could be more time for each session. But overall the conference was really good.

Bharat Bhushan

The Ohio State University

I believe this is one of the best conferences that I have attended and I've attended a huge number of conferences. The whole event was a great success for everyone and I will definitely attend future events.

Ramesh K. Agarwal

Washington University

Thank you very much for organizing this interesting and useful Conference. It was a very good and interesting conference indeed.

Chandra P. Sharma

Sree Chitra Tirunal Institute for Medical Sciences & Technology

The level of expertise and knowledge of the presenters are excellent. In addition, I appreciate their positive attitudes, willingness to explain concepts, clarity of visual aids and handouts, and opportunities to ask questions.